Cost-effectiveness analysis of carbetocin versus oxytocin for the prevention of postpartum hemorrhage following vaginal birth in the United Kingdom.

Suzette MatthijsseFredrik L Andersson Michael GarganoYum L Yip Sonderegger

Published in: Journal of medical economics (2022)

Carbetocin utilization leads to lower prophylactic treatment costs and less PPH events versus oxytocin when utilized for the prevention of PPH following vaginal birth in the UK.

Keyphrases

gestational age
cross sectional
pregnancy outcomes
combination therapy
replacement therapy